Share Tuesday, February 26, 2013, 4:30pm-6:40pm PST Talks in this session will cover the considerations and approaches for managing risk in the context of QbD principles. Talks will include identifying and assessing risk and effectively managing it through understanding CQAs and process design space. Understanding and mitigating the risk introduced by raw materials will also be covered in this session.Session Co-Chairs:Anthony Mire-Sluis, AmgenLynne Krummen, GenentechConfirmed SpeakersGreg Nyberg, AmgenAnn Subashi, Pfizer: Appropriate Use of Risk Management Tools in Biopharmaceutical DevelopmentMary Cromwell, GenentechChristoph Stark, Novartis Ann Subashi Ann Subashi is an Associate Director in Global CMC at Pfizer where she supports the Biotherapeutics New Products portfolio. Read more
Ann Subashi Ann Subashi is an Associate Director in Global CMC at Pfizer where she supports the Biotherapeutics New Products portfolio. Read more